Uncategorized – Page 17 – RedETSA

All

6 January, 2016

Economic evaluation of the use of oxytocin in the Uniject™ injection system versus standard use in ampoules for the prevention of postpartum hemorrhage in the active management of the third stage of labor in Latin America and the Caribbean

The Institute for Clinical and Healthcare Effectiveness (IECS), the Organization […]

6 January, 2016

Economic evaluation of oxytocin in Uniject™ injection system versus standard use of oxytocin for the prevention of postpartum hemorrhage in the active management of the third stage of labor in Latin America and the Caribbean.

The Institute for Clinical Effectiveness and Health Policy (IECS), the […]

5 January, 2016

Brazilian Valuation of EQ-5D-3L Health States: Results from a Saturation Study

Recent publication in Medical Decision Making (MDM) by NATS-INC on board […]

5 January, 2016

Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis

Abstract: Postpartum hemorrhage (PPH) is a leading cause of maternal […]

22 December, 2015

Highlights of the 5th Latin American Conference of ISPOR and Annual Meeting of RedETSA – Payment Filing

Two points discussed both at ISPOR and at the meeting […]

22 December, 2015

Highlights of the 5th ISPOR Latin American Conference and RedETSA Annual Meeting – Payment Threshold

Highlights of the 5th ISPOR Latin American Conference and RedETSA […]

22 December, 2015

Pharmacoepidemiology Research on Essential Medicines

It was carried out on November 23 to 25, […]

15 December, 2015

“Smoking and mortality – all proven causes”

Or study “Smoking and Mortality — Beyond Established Causes,” published […]

20 July, 2015

Methodologies and Resources related to different stages of HTA

The Institute of Health Economics (IHE), Alberta-Canada, recently published a […]

English